Abstract: The present invention relates to a compound of Formula (I), or a stereoisomer, solvate, tautomer or pharmaceutically acceptable salt thereof, wherein X, W1, W2, Y, Z, R1, R2 and R3 are as defined in the disclosure herein, for use in therapy, particularly for use in the treatment of cancer. The present invention also relates to methods of treating cancer comprising the administration of a compound of Formula (I) to a subject in need thereof, and to pharmaceutical compositions and kits comprising such compounds.
Type:
Grant
Filed:
February 3, 2020
Date of Patent:
April 23, 2024
Assignee:
HEMISPHERIAN AS
Inventors:
Adam Brian Robertson, Terezia Prikrylova